Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 4 × Patient Acceptance of Health Care × Epirubicin × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Breast Neoplasms 5 Wilms Tumor 1 Recurrence 1 Patient Acceptance of Health Care 1 Non-Muscle Invasive Bladder Neoplasms 1 Neoplastic Cells, Circulating 1 Neoplasms 1 Carcinoma, Hepatocellular 1

Interventions

palbociclib 1 exemestane 1 Vinorelbine 1 Tamoxifen 1 Paclitaxel 1 Letrozole 1 Fulvestrant 1 Epirubicin 1 Drug Therapy 1 Capecitabine 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT03355157 2024-10-01

PADMA

GBG Forschungs GmbH

Phase 4 Completed

Breast Neoplasms, Patient Acceptance of Health Care

Data powered by HemOnc (CC BY 4.0) Colophon ⚡